{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:19:55Z","timestamp":1790716795606,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1141,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1111\/j.1524-4733.2010.00694.x","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T07:08:30Z","timestamp":1268204910000},"page":"418-423","source":"Crossref","is-referenced-by-count":32,"title":["Quantifying Women's Stated Benefit\u2013Risk Trade-Off Preferences for IBS Treatment Outcomes"],"prefix":"10.1016","volume":"13","author":[{"given":"F. Reed","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Brett","family":"Hauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Lynd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1524-4733.2010.00694.x_bib10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archinte.165.12.1363","article-title":"Adverse drug event surveillance and drug withdrawals in the United States, 1969\u20132002: the importance of reporting suspected reactions","volume":"165","author":"Wysowski","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/pds.1319","article-title":"A call for international harmonization in therapeutic risk management","volume":"15","author":"Hirst","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib30","series-title":"The Future of Drug Safety: Promoting and Protecting the Health of the Public","author":"Institute of Medicine","year":"2007"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2001.03626.x","article-title":"Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients","volume":"96","author":"Wolfe","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib50","article-title":"Using the incremental net benefit framework for quantitative benefit\u2013risk analysis in regulatory decision-making\u2014a case study of alosetron in irritable bowel syndrome","author":"Lynd","year":"2009","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib60","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MLR.0b013e318040ad90","article-title":"Factors that affect adherence to bipolar disorder treatments\u2014a stated-preference approach","volume":"45","author":"Johnson","year":"2007","journal-title":"Med Care"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib70","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhealeco.2006.01.001","article-title":"Using discrete choice experiments to estimate a preference-based measure of outcome\u2014an application to social care for older people","volume":"25","author":"Ryan","year":"2006","journal-title":"J Health Econ"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib80","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2133.2006.07535.x","article-title":"Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with UK dermatologists","volume":"155","author":"Ashcroft","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib90","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/j.gastro.2007.04.075","article-title":"Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy","volume":"133","author":"Johnson","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib100","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1089\/jwh.2006.0218","article-title":"Women's willingness to accept perceived risks for vasomotor symptom relief","volume":"16","author":"Johnson","year":"2007","journal-title":"J Womens Health"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2307\/3151882","article-title":"Efficient experimental design with marketing research applications","volume":"31","author":"Kuhfeld","year":"1994","journal-title":"J Mark Res"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib120","series-title":"Orthogonal Fractional Factorial Designs","author":"Dey","year":"1985"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2307\/3152127","article-title":"The importance of utility balance in efficient choice designs","volume":"33","author":"Huber","year":"1996","journal-title":"J Mark Res"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib140","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1509\/jmkr.39.2.214.19080","article-title":"Optimal design for multinomial choice experiments","volume":"39","author":"Kanninen","year":"2002","journal-title":"Journal of Marketing Research"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib150","unstructured":"Zwerina K, Huber J, Kuhfeld WF. A general method for constructing efficient choice designs. SAS Working Paper, 2006."},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib160","author":"Ipsos Observer"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib170","series-title":"Discrete Choice Methods with Simulation","author":"Train","year":"2003"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib180","series-title":"Gauss 7.0 [Computer Program]","year":"2005"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib190","series-title":"Applied Choice Analysis: A Primer","author":"Hensher","year":"2005"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib200","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","article-title":"A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome","volume":"161","author":"Camilleri","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1524-4733.2010.00694.x_bib210","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(00)02033-X","article-title":"Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial","volume":"355","author":"Camilleri","year":"2000","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1111\/j.1524-4733.2010.00694.x_bib220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2036.1999.00010.x","article-title":"Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients","volume":"13","author":"Mangel","year":"1999","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510600769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510600769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T17:54:17Z","timestamp":1544637257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510600769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1098301510600769"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-4733.2010.00694.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}